bullish
Paramount Bed (7817 JP): Record High Revenue Clocked in FY22; New Management Target Announced
344 Views09 Jul 2022 23:10
SUMMARY
- Paramount Bed Holdings Co Lt (7817 JP) announced record high sales in FY22, driven by strong demand of hospital beds and achieved management target two year ahead of plan.
- While near-term challenges including high input cost and semiconductor supply shortage negatively impact FY23 performance, Paramount aims to achieve 33% revenue growth and 50bps operating margin expansion during FY22–27.
- Paramount is a strong play on COVID recovery. The shares gained 15% since I published bullish note on the company on January 17, 2022. More stream is still left.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Rising
Tina Banerjee
Global Healthcare Analyst
- Paramount Bed Holdings (7817 JP): In-Line Q1 Result; FY24 Guidance Reaffirmed22 Sep 2023
- Paramount Bed (7817 JP): All-Time Revenue and Profit in FY23; Further Upside Potential Remains14 Jun 2023
- Paramount Bed (7817 JP): Record High Revenue Clocked in FY22; New Management Target Announced09 Jul 2022
- Paramount Bed (7817 JP): Poised to Grow on the Back of Recovery from the COVID-1918 Jan 2022
x